Study of rheological and tableting properties of lubricated mixtures of co-processed dry binders for orally disintegrating tablets
Co-processed dry binders for ODTs are important multifunctional excipients for tablet manufacturing by direct compression. Testing their binary mixtures with lubricants is an important aspect of their use in combination with drugs. The aim of this study was to evaluate the rheological and compression properties of lubricated mixtures of co-processed dry binders Parteck® ODT, Prosolv® ODT G2 and Ludiflash®, and subsequently also the compactability and disintegration time of the tablets made thereof.
Co-processed dry binders for ODT are multifunctional excipients
The energy of pre-compression depends on the angle of internal friction
Microcrystalline cellulose improves compression and tableting properties
Composition of co-processed dry binders is more important than compression force
Friability correlates with the tensile strength of tablets
Disintegration time may not directly depend on wettability and porosity
The lubricants employed were magnesium stearate and sodium stearyl fumarate in the concentrations of 0.5% and 1%. The best flowability was shown by Prosolv® ODT G2 combined with magnesium stearate in the concentration of 0.5%. Lubricated mixtures with Prosolv® ODT G2 showed a lower angle of internal friction as well as lower pre-compression energy values. The values of plastic deformation energy were the highest in the case of Prosolv® ODT G2, which was also reflected in the highest tablet strength.
On the contrary, the ejection force values were the lowest for this co-processed dry binder. Magnesium stearate reduced the ejection force more effectively than sodium stearyl fumarate. Prosolv® ODT G2 tablets exhibited the highest tensile strength and shortest disintegration time.
Article information: Thao Tranová, Oliver Macho, Jan Loskot, Jitka Mužíková, Study of rheological and tableting properties of lubricated mixtures of co-processed dry binders for orally disintegrating tablets., European Journal of Pharmaceutical Sciences, 2021. https://doi.org/10.1016/j.ejps.2021.106035.